Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1985
Deletion mapping of HLA and chromosome 6p genesF Levine, H Erlich, B Mach, et al.Nature|January 4, 1990
Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genesE Mellins, L Smith, B Arp, et al.The EMBO Journal|July 1, 1988
Two distinct genetic loci regulating class II gene expression are defective in human mutant and patient cell linesZ Yang, R S Accolla, D Pious, et al.The Journal of Experimental Medicine|December 1, 1979
Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector levelM Lipinski, W H Fridman, T Tursz, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1982
HLA antigen structural gene mutants selected with an allospecific monoclonal antibodyD Pious, M S Krangel, L L Dixon, et al.The Journal of Experimental Medicine|February 1, 1994
A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptidesE Mellins, P Cameron, M Amaya, et al.Immunogenetics|January 1, 1984
Mutant HLA-A2 antigens as restricting elements for virus-specific cytotoxic T cellsJ S Gaston, L E Wallace, A B Rickinson, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1983
Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte lineC F Ware, M S Krangel, D Pious, et al.Proceedings of the National Academy of Sciences of the United States of America|November 1, 1986
Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complexT Spies, C C Morton, S A Nedospasov, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 1990
Point mutations define positions in HLA-DR3 molecules that affect antigen presentationE Mellins, B Arp, D Singh, et al.Pageof 5